Posted by
on Jan 16th, 2012 and filed under Warning: Don’t Sell on This News – DailyFinance
DailyFinance
By Brian Orelli, The Motley Fool Posted 8:39AM 01/15/12 Investing Seattle Genetics (NAS: SGEN) fell quite a bit after the company announced a change to the warnings section of the label for its blood cancer drug Adcetris. The label warns of a possible …
Seattle Genetics Drug Gets Boxed Warning on Infection Risk
Cancer drug gets stronger label warning
Seattle Genetics Sees Updated Side Effect Warning in Drug Label
Warning: Don’t Sell on This News – DailyFinance Warning: Don't Sell on This NewsDailyFinanceBy Brian Orelli, The Motley Fool Posted 8:39AM 01/15/12 Investing Seattle Genetics (NAS: SGEN) fell quite a bit after the company announced a change to the warnings section of the label for its blood cancer drug Adcetris. The label warns of a [...]
